Skip to main content
. 2015 Jul-Aug;9(7-8):242–247. doi: 10.5489/cuaj.2711

Table 4.

SNM vs. BonT-A and OMT probabilistic analysis

SNM vs. BonT-A % <Cost-effective threshold

Mean Low range High range

1 year 0.50% 0.10% 0.40%
2 years 26.70% 21.60% 48.60%
4 years 94.40% 95.60% 93.90%
5 years 93.20% 94.60% 89.40%
10 years 85.80% 88.60% 77.70%
SNM vs. OMT % <Cost-effective threshold

Mean Low range High range

1 year 17.90% 22.00% 9.40%
2 years 99.90% 99.80% 100.00%
4 years 99.60% 99.60% 100.00%
5 years 99.60% 99.60% 100.00%
10 years 64.70% 61.40% 78.00%

QALY: quality-adjusted life years; SNM: sacral-neuromodulation; BonT-A: botulinum-toxin-A; OMT: optimized medical-therapy.